CREO — Creo Medical Cashflow Statement
0.000.00%
Last trade - 00:00- £46.40m
- £30.10m
- £4.00m
- 54
- 63
- 29
- 44
Annual cashflow statement for Creo Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.3 | -24.6 | -26.9 | -21.7 | -27.8 |
| Depreciation | |||||
| Non-Cash Items | -2.3 | -2.65 | -2.4 | -1.9 | 1.5 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.74 | -1.33 | 1.3 | -1.4 | 1.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.3 | -26 | -24.9 | -21.6 | -22.2 |
| Capital Expenditures | -0.576 | -6.12 | -3.3 | -1.6 | -0.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -20.4 | -1.72 | -2.7 | -16.7 | 15.7 |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21 | -7.84 | -6 | -18.3 | 15.3 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.33 | 32 | 0.4 | 29.8 | 16.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -36 | -1.56 | -30.4 | -10.1 | 9.3 |